The future of vaccines, immunisation concepts and practice

被引:22
作者
André, FE [1 ]
机构
[1] GlaxoSmithKline Biol, B-1330 Rixensart, Belgium
关键词
future; vaccines; immunisation;
D O I
10.1016/S0264-410X(00)00546-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccines have prevented more deaths, disability and suffering than any other medical discovery or intervention. Recent breakthroughs in immunology and genomics offer the prospect of the development of many new prophylactic and therapeutic vaccines not only against infectious diseases but also for use in conditions such as allergy, autoimmunity and carcinogenesis where malfunction of the immune system undoubtedly plays a role. These hopeful perspectives are however dimmed by several counterproductive societal trends that include the spreading-although unjustified-belief that vaccines are not safe and may even be unnecessary, escalating costs of vaccine research, development, production and control that are exacerbated by political pressure on selling prices and expensive lawsuits by 'victims' of vaccination who claim excessive compensation. Negative media coverage of vaccine issues is adversely affecting acceptance of vaccination. In spite of these negative trends. vaccines should have a bright future, because it is increasingly being realised that prevention is not only better than cure but it is often also more cost-effective. A better understanding of the dynamics of microbial transmission in populations is leading to more rational immunisation practices on a global scale that could lead to eradication of several pathogens. Attention is being given to making vaccines more user-friendly through the development of combined vaccines and the introduction of less invasive inoculation techniques. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2206 / 2209
页数:4
相关论文
共 21 条
[1]  
ANDERSON R M, 1991
[2]   Development and clinical application of new polyvalent combined paediatric vaccines [J].
André, FE .
VACCINE, 1999, 17 (13-14) :1620-1627
[3]   Broadening the approaches to developing more effective vaccines [J].
Babiuk, LA .
VACCINE, 1999, 17 (13-14) :1587-1595
[4]   Demographic impact of vaccination: a review [J].
Bonanni, P .
VACCINE, 1999, 17 :S120-S125
[5]  
BRUNDTLAND GH, 1999, WORLD HLTH REPORT 19
[6]   Genomic tools for gene and protein discovery in malaria: toward new vaccines [J].
Carucci, DJ .
VACCINE, 2001, 19 (17-19) :2315-2318
[7]   Vaccines and mucosal immunisation [J].
Cripps, AW ;
Kyd, JM ;
Foxwell, AR .
VACCINE, 2001, 19 (17-19) :2513-2515
[8]   Vaccine safety: risk communication - a global perspective [J].
Dittmann, S .
VACCINE, 2001, 19 (17-19) :2446-2456
[9]  
EDELMAN R, 1997, NEW GENERATION VACCI, P173
[10]   New technologies for making vaccines [J].
Ellis, RW .
VACCINE, 1999, 17 (13-14) :1596-1604